NO895338D0 - Fremgangsmaate og terapeutiske preparater for forhindring av fibrinavsetning eller adhesjoner. - Google Patents

Fremgangsmaate og terapeutiske preparater for forhindring av fibrinavsetning eller adhesjoner.

Info

Publication number
NO895338D0
NO895338D0 NO1989895338A NO895338A NO895338D0 NO 895338 D0 NO895338 D0 NO 895338D0 NO 1989895338 A NO1989895338 A NO 1989895338A NO 895338 A NO895338 A NO 895338A NO 895338 D0 NO895338 D0 NO 895338D0
Authority
NO
Norway
Prior art keywords
adhesions
prevention
procedure
therapeutic preparations
fibrin deposit
Prior art date
Application number
NO1989895338A
Other languages
English (en)
Other versions
NO301748B1 (no
NO895338L (no
Inventor
Marjorie A Mohler
Tue H Nguyen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NO895338D0 publication Critical patent/NO895338D0/no
Publication of NO895338L publication Critical patent/NO895338L/no
Publication of NO301748B1 publication Critical patent/NO301748B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO895338A 1987-07-01 1989-12-29 Fremgangsmåte for fremstilling av et farmasöytisk preparat for forhindring av fibrinavsetning eller adhesjonsdannelse eller -nydannelse NO301748B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6887287A 1987-07-01 1987-07-01
US12531987A 1987-11-25 1987-11-25
US21089588A 1988-06-24 1988-06-24
PCT/US1988/002194 WO1989000049A1 (en) 1987-07-01 1988-06-30 Method and therapeutic compositions for the prevention of fibrin deposition or adhesions

Publications (3)

Publication Number Publication Date
NO895338D0 true NO895338D0 (no) 1989-12-29
NO895338L NO895338L (no) 1990-02-28
NO301748B1 NO301748B1 (no) 1997-12-08

Family

ID=27371438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO895338A NO301748B1 (no) 1987-07-01 1989-12-29 Fremgangsmåte for fremstilling av et farmasöytisk preparat for forhindring av fibrinavsetning eller adhesjonsdannelse eller -nydannelse

Country Status (14)

Country Link
EP (1) EP0297860B1 (no)
JP (1) JP2756131B2 (no)
KR (1) KR0131330B1 (no)
AU (1) AU621305B2 (no)
DE (1) DE3883645T2 (no)
DK (1) DK175597B1 (no)
FI (1) FI103868B1 (no)
IE (1) IE65658B1 (no)
IL (2) IL86933A (no)
NO (1) NO301748B1 (no)
NZ (1) NZ225260A (no)
PH (1) PH26527A (no)
PT (1) PT87886B (no)
WO (1) WO1989000049A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
WO1995001292A1 (en) * 1993-07-02 1995-01-12 Quest International Bv. Packaging of enzymes
US5869810A (en) * 1995-05-23 1999-02-09 Victor Reynolds Impedance-heated furnace
DE19529223A1 (de) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
US7067485B2 (en) 1997-11-07 2006-06-27 Chiron Corporation IGF-I composition and its use
WO1999024062A1 (en) * 1997-11-07 1999-05-20 Chiron Corporation Novel igf-i composition and its use
FR2918276B1 (fr) 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
JPS6218742A (ja) * 1985-07-18 1987-01-27 Sony Corp ヒ−トシンクの製造方法
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
KR870005646A (ko) * 1985-12-16 1987-07-06 로버트 엘. 미니어 수술후 유착형성 억제방법

Also Published As

Publication number Publication date
KR890701124A (ko) 1989-12-19
JP2756131B2 (ja) 1998-05-25
NO301748B1 (no) 1997-12-08
DK675389D0 (da) 1989-12-29
DE3883645T2 (de) 1994-02-03
PH26527A (en) 1992-08-07
DE3883645D1 (de) 1993-10-07
FI896359A0 (fi) 1989-12-29
IE65658B1 (en) 1995-11-15
IL102625A0 (en) 1993-01-14
FI103868B (fi) 1999-10-15
FI103868B1 (fi) 1999-10-15
PT87886A (pt) 1989-06-30
WO1989000049A1 (en) 1989-01-12
JPH04502753A (ja) 1992-05-21
NO895338L (no) 1990-02-28
NZ225260A (en) 1991-03-26
KR0131330B1 (ko) 1998-04-17
DK675389A (da) 1990-02-28
EP0297860B1 (en) 1993-09-01
IL86933A (en) 1993-07-08
IE882023L (en) 1989-01-01
DK175597B1 (da) 2004-12-13
AU1998588A (en) 1989-01-30
PT87886B (pt) 1993-09-30
EP0297860A1 (en) 1989-01-04
AU621305B2 (en) 1992-03-12

Similar Documents

Publication Publication Date Title
NO884807L (no) Fremgangsmaate og anordning for utbedring av foringsroer.
NO170394C (no) Fremgangsmaate og system for behandling av dispersjoner avborkaks og lignende
DK10289A (da) Fremgangsmaade og praeparater til forebyggelse af ulcus
NO165398C (no) Analogifremgangsmaate og fremstilling av terapeutisk aktive nitrofuranderivater.
NO164219C (no) Fremgangsmaate og anlegg for behandling av returnert boreslam.
NO895338D0 (no) Fremgangsmaate og terapeutiske preparater for forhindring av fibrinavsetning eller adhesjoner.
NO893142L (no) Fremgangsmaate for preservering av oftalmologiske opploesninger og sammensetninger for formaalet.
NO167664C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider.
NO882462D0 (no) Fremstilling og bruk av fenolderivater.
EP0223254A3 (en) Preparations for the treatment and prevention of epithelial destruction
NO901272L (no) Sammensetning og fremgangsmaate for fjerning av sulfider.
NO884324D0 (no) Fremgangsmaate til fremstilling av reninhemmende peptider og deres anvendelse.
NO881713L (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO891630D0 (no) Fremgangsmaate og anordning for fremstilling av diafragmer.
NO883927L (no) Staal og anvendelse av dette.
NO882336D0 (no) Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener.
NO884818D0 (no) Fremgangsmaate og mellomprodukter for fremstilling av halogenerte proteasehemmere.
NO884635D0 (no) Fremgangsmaate for behandling av most.
NO891986L (no) Fremgangsmaate for fremstilling av difenyl-sulfider, difenyl-sulfoksyder og difenylsulfoner.
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
ZA884739B (en) Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
NO901421D0 (no) Intranasal administrering av fysostigmin og arecolin.
NO912279D0 (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.
NO165155C (no) Framgangsmaate for bygging og demontering av bygningsdeler.
NO872673L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinoksalindioner og kinolindioner.

Legal Events

Date Code Title Description
MK1K Patent expired